PCATs are based on nomograms published in the Journal of Urology to ensure highly accurate assessments. Nomograms are paper-based decision-making statistical tools that are comprised of information from thousands of real-life observations from documented prostate cancer cases.

The tools assist patients and physicians in decision making by providing calculated predictions of the outcomes of various stages of treated prostate cancer.

The nomograms behind the 12 PCATs have an average accuracy rate of 80 per cent, and are of significant benefit to patients in that they eliminate bias and subjectivity that is inherent in the perspective of individual clinicians and caregivers.

To create this program for Canadian men, Prostate Cancer Canada partnered with a team of highly recognized researchers led by Dr. Pierre Karakiewicz, MD, urologist and director of the Cancer Prognostics and Health Outcomes Unit at the University of Montreal Health Centre.

Information published on the Prostate Cancer Canada website is provided for informational and educational purposes only. Information provided on this website, including information derived from the Prostate Cancer Assessment Tools (PCATs) and the prostate cancer nomograms, is not designed or intended to constitute medical advice or to be used for diagnosis. The PCATs are intended to provide information on your condition and to help inform your consultations with medical professionals. The information obtained from this website should not be a substitute for medical advice from a qualified medical professional.

Prostate Cancer Canada and the Centre Hospitalier de l'Université de Montréal assume no responsibility or liability for any consequence resulting directly or indirectly for any action or inaction you take based on or made in reliance on the information, services, or material on or linked to this site.

Please continue here if you would like to use the PCATs.